Clinical Trials

SonoLysis+tPA Therapy
Phase I / II study evaluating our proprietary MRX-801 microbubbles, ultrasound and tPA for the treatment of acute ischemic stroke.

ImaRx is conducting an immunogenicity trial with Abbokinase® to evaluate patients' immune response to this marketed product.

Terms of Use Contact Us Site Map
Copyright © 2000 - 2008 ImaRx Therapeutics, Inc. All rights reserved.